|
SG11201600853UA
(en)
|
2013-08-05 |
2016-03-30 |
Twist Bioscience Corp |
De novo synthesized gene libraries
|
|
WO2016126882A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
AU2016324296A1
(en)
|
2015-09-18 |
2018-04-12 |
Twist Bioscience Corporation |
Oligonucleic acid variant libraries and synthesis thereof
|
|
KR102794025B1
(ko)
|
2015-09-22 |
2025-04-09 |
트위스트 바이오사이언스 코포레이션 |
핵산 합성을 위한 가요성 기판
|
|
CN115920796A
(zh)
|
2015-12-01 |
2023-04-07 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
CN116731156A
(zh)
*
|
2016-03-16 |
2023-09-12 |
伊玛提克斯生物技术有限公司 |
用于癌症免疫治疗的转染t细胞和t细胞受体
|
|
GB2568444A
(en)
|
2016-08-22 |
2019-05-15 |
Twist Bioscience Corp |
De novo synthesized nucleic acid libraries
|
|
JP6871364B2
(ja)
|
2016-09-21 |
2021-05-12 |
ツイスト バイオサイエンス コーポレーション |
核酸に基づくデータ保存
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
KR20240007775A
(ko)
|
2016-12-08 |
2024-01-16 |
이매틱스 바이오테크놀로지스 게엠베하 |
T 세포 수용체 및 이를 사용하는 면역 요법
|
|
JP7169975B2
(ja)
*
|
2016-12-16 |
2022-11-11 |
ツイスト バイオサイエンス コーポレーション |
免疫シナプスの変異体ライブラリーおよびその合成
|
|
EP3586255B1
(en)
|
2017-02-22 |
2025-01-15 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
CA3056388A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
SG10202107869QA
(en)
*
|
2017-04-10 |
2021-08-30 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
EP3638782A4
(en)
|
2017-06-12 |
2021-03-17 |
Twist Bioscience Corporation |
SEALLESS NUCLEIC ACID ASSEMBLY METHODS
|
|
GB2581620A
(en)
|
2017-09-11 |
2020-08-26 |
Twist Bioscience Corp |
GPCR binding proteins and synthesis thereof
|
|
CA3081336A1
(en)
*
|
2017-10-12 |
2019-04-18 |
Gregory LIZEE |
T cell receptors for immunotherapy
|
|
WO2019079769A1
(en)
|
2017-10-20 |
2019-04-25 |
Twist Bioscience Corporation |
HEATED NANOWELLS FOR THE SYNTHESIS OF POLYNUCLEOTIDES
|
|
CN120485344A
(zh)
|
2018-01-04 |
2025-08-15 |
特韦斯特生物科学公司 |
基于dna的数字信息存储
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
JP2021526366A
(ja)
|
2018-05-18 |
2021-10-07 |
ツイスト バイオサイエンス コーポレーション |
核酸ハイブリダイゼーションのためのポリヌクレオチド、試薬、および方法
|
|
EP3847266A1
(en)
*
|
2018-09-05 |
2021-07-14 |
GlaxoSmithKline Intellectual Property Development Ltd |
T cell modification
|
|
JP7528058B2
(ja)
*
|
2018-09-14 |
2024-08-05 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Ｔｃｒリガンドの高スループットペプチド－ｍｈｃ親和性スクリーニングのための方法
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
CA3124980A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
AU2020227802A1
(en)
|
2019-02-26 |
2021-10-14 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
US11492727B2
(en)
|
2019-02-26 |
2022-11-08 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for GLP1 receptor
|
|
WO2020191172A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN114375301B
(zh)
*
|
2019-05-08 |
2025-08-05 |
基因医疗免疫疗法有限责任公司 |
工程改造的t细胞
|
|
PH12021552979A1
(en)
|
2019-05-27 |
2023-10-09 |
Immatics Us Inc |
Viral vectors and their use in adoptive cellular therapy
|
|
JP7730765B2
(ja)
*
|
2019-06-18 |
2025-08-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｍａｇｅ－ａ４ ｔ細胞受容体およびその使用方法
|
|
CA3144054A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
AU2020298294A1
(en)
|
2019-06-21 |
2022-02-17 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
US20220281949A1
(en)
*
|
2019-07-30 |
2022-09-08 |
University Health Network |
Mhc class ii molecules and methods of use thereof
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
AU2020356471A1
(en)
|
2019-09-23 |
2022-04-21 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for CRTH2
|
|
WO2021061842A1
(en)
|
2019-09-23 |
2021-04-01 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for single domain antibodies
|
|
WO2021141985A1
(en)
*
|
2020-01-06 |
2021-07-15 |
Memorial Sloan-Kettering Cancer Center |
Novel dominant negative fas polypeptides, cells comprising thereof and uses thereof
|
|
CA3168729A1
(en)
|
2020-02-24 |
2021-09-02 |
Melinda MATA |
Methods for expanding t cells for the treatment of cancer and related malignancies
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
US20220056411A1
(en)
*
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
JP7644421B2
(ja)
*
|
2020-10-07 |
2025-03-12 |
ダアン バイオセラピュティクス カンパニー、リミテッド |
Ｔ細胞受容体、ｔ細胞受容体を含む免疫細胞およびそれを用いる方法｛ｔ ｃｅｌｌ ｒｅｃｅｐｔｏｒｓ、ｉｍｍｕｎｅ ｃｅｌｌ ｃｏｍｐｒｉｓｉｎｇ ｔ ｃｅｌｌ ｒｅｃｅｐｔｏｒｓ ａｎｄ ｍｅｔｈｏｄ ｕｓｉｎｇ ｔｈｅ ｓａｍｅ｝
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
WO2022147029A2
(en)
|
2020-12-31 |
2022-07-07 |
Immatics US, Inc. |
Cd8 polypeptides, compositions, and methods of using thereof
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
EP4326751A1
(en)
*
|
2021-04-21 |
2024-02-28 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
CA3217739A1
(en)
|
2021-05-05 |
2022-11-10 |
Sebastian Bunk |
Bma031 antigen binding polypeptides
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
US20230089392A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
CA3236646A1
(en)
*
|
2021-11-03 |
2023-05-11 |
Ji Wang |
Novel anti-l1cam antibody
|
|
WO2023081461A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
EP4448108A1
(en)
|
2021-11-08 |
2024-10-23 |
Immatics Biotechnologies GmbH |
Adoptive cell therapy combination treatment and compositions thereof
|
|
CA3247928A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems and methods for programming T-lymphocyte phenotypes by targeted gene repression
|
|
CA3247927A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems and methods for programming T-lymphocyte phenotypes by targeted gene repression
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
WO2023212655A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
WO2023212691A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
DOMINANT NEGATIVE TGFβ RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF
|
|
WO2023212697A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
EP4519418A1
(en)
|
2022-05-05 |
2025-03-12 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
WO2023250168A2
(en)
*
|
2022-06-24 |
2023-12-28 |
Amgen Inc. |
Magea4 specific t cell receptors
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
WO2024064642A2
(en)
|
2022-09-19 |
2024-03-28 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for modulating t cell function
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
US20250134931A1
(en)
|
2023-11-01 |
2025-05-01 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233432A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use and dosage of an antigen-binding protein comprising a tcr specific for an hla-a*02 restricted peptide
|
|
WO2026008886A1
(en)
|
2024-07-05 |
2026-01-08 |
Immatics Biotechnologies Gmbh |
Means and methods for the quantification of target expression
|